Open access · OA
via Europe PMC
Changes of serum fibroblast growth factor 23 (FGF23) and Klotho in diabetic kidney disease and their correlation with coronary artery calcification: a retrospective study.
Hong Y, Wang J, Lu Q, Sun W, Sun J.
Archives of endocrinology and metabolism · 2026
Abstract
<h4>Objective</h4>This study investigated the association among fibroblast growth factor 23 (FGF23), Klotho, and coronary artery calcification (CAC) in patients with diabetic kidney disease (DKD).<h4>Subjects and methods</h4>A total of 176 DKD patients and 160 age-and diabetes-matched controls were retrospectively analyzed. We measured serum FGF23 and Klotho levels by enzyme-linked immunosorbent assay and assessed CAC by CAC scoring. Correlation and receiver operating characteristic analyses were performed to evaluate the associations of these biomarkers with CAC and their ability to discriminate CAC.<h4>Results</h4>FGF23 levels were significantly higher and Klotho levels were lower in patients with DKD than in controls. FGF23 correlated negatively with estimated glomerular filtration rate and positively with the albumin-to-creatinine ratio and blood urea nitrogen, whereas Klotho correlated positively with estimated glomerular filtration rate and negatively with albumin-to-creatinine ratio and blood urea nitrogen. In patients with CAC, FGF23 levels were higher and Klotho levels were lower. Receiver operating characteristic analysis showed that both FGF23 and Klotho discriminated CAC, and FGF23 showed a higher area under curve than Klotho. Correlation analysis further confirmed the association of FGF23 and Klotho with CAC severity.<h4>Conclusion</h4>FGF23 and Klotho were associated with renal impairment and CAC in patients with DKD and may serve as potential biomarkers of renal and cardiovascular risk.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.20945/2359-4292-2026-0125
- Canonical
- link ↗
- Fetched
- 2026-10-25 MST
Cite this
APA
Y, H., J, W., Q, L., W, S., & J., S. (2026). Changes of serum fibroblast growth factor 23 (FGF23) and Klotho in diabetic kidney disease and their correlation with coronary artery calcification: a retrospective study. <em>Archives of endocrinology and metabolism</em>. https://doi.org/10.20945/2359-4292-2026-0125
Vancouver
Y H, J W, Q L, W S, J. S. Changes of serum fibroblast growth factor 23 (FGF23) and Klotho in diabetic kidney disease and their correlation with coronary artery calcification: a retrospective study. Archives of endocrinology and metabolism. 2026. doi:10.20945/2359-4292-2026-0125.
BibTeX
@article{hong2026Change,
title = {Changes of serum fibroblast growth factor 23 (FGF23) and Klotho in diabetic kidney disease and their correlation with coronary artery calcification: a retrospective study.},
author = {Hong Y and Wang J and Lu Q and Sun W and Sun J.},
journal = {Archives of endocrinology and metabolism},
year = {2026},
doi = {10.20945/2359-4292-2026-0125},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Medical Bulletin of Haseki 2026
Open access · CC-BY
Association of Circulating FGF-23 and Klotho with Cardiovascular Disease in Patients with Chronic Kidney Disease
PubMed 2017
Preprint
[Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].
Therapeutic Advances in Chronic Disease 2023
Open access · CC-BY
Potential application of Klotho as a prognostic biomarker for patients with diabetic kidney disease: a meta-analysis of clinical studies
Chin J Postgrad Med 2014
Citation only
The level of serum Klotho in patients with chronic kidney disease and its relationship with renal function
Diabetes Therapy 2025
Open access · CC-BY
Association Between Serum α-Klotho Levels and Diabetic Kidney Disease Prevalence in Middle-Aged and Elderly US Patients with Diabetes: A Cross-Sectional Study Using NHANES 2007–2016 Data
Nephrology Dialysis Transplantation 2017
Open access · OA